Zobrazeno 1 - 10
of 25
pro vyhledávání: '"José Antonio García-Vela"'
Autor:
Diego Velasco-Rodríguez, Miguel Piris-Villaespesa, Carmen Soteras, Ana Vallés, José Antonio García-Marco, José Antonio García-Vela
Publikováno v:
Case Reports in Hematology, Vol 2017 (2017)
Chronic lymphocytic leukemia (CLL) is an incurable lymphoproliferative disorder with a heterogeneous genetic and clinical course. Two kinase inhibitors, ibrutinib and idelalisib, have demonstrated achievement of complete and durable remissions in rel
Externí odkaz:
https://doaj.org/article/7e59accaef964db983d027d58e869d4c
Autor:
José Antonio García-Vela, Fernando Martín-Moro, Ana Lario, Berta M Michael, Irene García, Juan Marquet-Palomanes, Miguel Piris-Villaespesa, Javier López-Jiménez, Ernesto Roldán, Mónica García-Cosío, Jesús Villarrubia
Publikováno v:
Cytometry Part B: Clinical Cytometry. 98:525-528
BACKGROUND The significance of discrepant findings between histology (BMB) and flow cytometry (FC) in bone marrow (BM) examination at diffuse large B-cell lymphoma (DLBCL) diagnosis is uncertain. METHODS We performed a 5-year retrospective single-cen
Autor:
Socorro María Rodríguez Pinilla, Elena Prieto Pareja, Ana Maria Dotor, José Antonio García Vela, Carlos Santonja, Francisca Inmaculada Camacho Castañeda, Rebeca Manso, Teresa Palomo Esteban, Miguel A. Piris, Paloma Martín
Publikováno v:
HistopathologyReferences. 77(1)
Aims To present four examples of clonally related Epstein-Barr virus (EBV)-associated large-cell transformation of marginal zone lymphoma (MZL) (of nodal, extranodal and splenic types), occurring 120, 11 and 5 months after the initial diagnosis in th
Publikováno v:
Medicina Clínica. 150:144-149
Resumen La evaluacion de la enfermedad minima residual (EMR) es un objetivo importante en el tratamiento de la leucemia linfocitica cronica (LLC). Su obtencion es predictiva de una supervivencia libre de progresion (SLP) y una supervivencia global pr
Autor:
Jaime Pçerez Oteyza, Esther Onecha, Rosalia Riaza, Marta Pratcorona, Miguel Gallardo, Elena Magro, Inmaculada Rapado, Teresa Cedena, María Linares, Eva Barragán, Pilar Martínez-Barranco, José Antonio García Vela, Pilar Herrera, A Figuera, Joaquin Martinez-Lopez, Eduardo Anguita, Pilar Martínez-Sánchez, Pau Montesinos, Beatriz Sanchez-Vega, Josep F. Nomdedeu, Yanira Ruiz-Heredia, Rosa Ayala
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
HAEMATOLOGICA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Haematologica
Biblos-e Archivo. Repositorio Institucional de la UAM
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Instituto de Salud Carlos III (ISCIII)
HAEMATOLOGICA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Haematologica
Biblos-e Archivo. Repositorio Institucional de la UAM
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
A high proportion of patients with acute myeloid leukemia who achieve minimal residual disease negative status ultimately relapse because a fraction of pathological clones remains undetected by standard methods. We designed and validated a high-throu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::133976c346fe8791adeda6aea1cfec98
https://hdl.handle.net/20.500.12105/6553
https://hdl.handle.net/20.500.12105/6553
Autor:
Carolina Sánchez-Rodríguez, José Antonio García-Vela, Laura Rodrigáñez Riesco, Ricardo Sanz-Fernández, Keyliz R. Peraza Cruces
Background: Recurrent tonsillitis might reduce the immunological capability of fighting against the infection of tonsil tissue. Polypodium leucotomos (Anapsos) immunomodulating effect has been subject of research in the last years. The aim of this re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adcf9b0a9a0854c91dfb68bb222938f3
https://hdl.handle.net/11268/7536
https://hdl.handle.net/11268/7536
Autor:
Miguel Casares, Rosario Granados, José Antonio García-Vela, Purificación Holguín Holgado, Isabel Sánchez-Muñoz, Celia Casares
Publikováno v:
Tissue Engineering Part A. 21:214-223
In recent years, the reconstruction of human skin by tissue engineering represents a clinical challenge and has offered a therapeutic alternative. Avascular engineered skin equivalents have been available for several years and used to treat wounds du
Publikováno v:
Medicina clinica. 150(4)
Minimal residual disease (MRD) assessment is an important endpoint in the treatment of chronic lymphocytic leukaemia (CLL). It is highly predictive of prolonged progression-free survival (PFS) and overall survival and could be considered a surrogate
Publikováno v:
American journal of hematology. 92(8)
Autor:
María Belén Vidriales, Andrea Mayado, Sergio Matarraz, María Isabel Prieto Conde, José Antonio García Vela, Susana Barrena, Daniela Damasceno, Félix López Cadenas, Vincent H.J. van der Velden, Pilar Leoz, Covadonga Quirós Caso, Alberto Orfao, Ramón García-Sanz, Xavier Calvo, Neus Villamor, Enrique Colado, María Díez-Campelo, Ariana Fonseca, Luis Alonso, Rosa Ayala Bueno, Leonor Arenillas, María C. Chillón, Laura Magnano, José I. Sánchez-Gallego, Sara Alonso, Carlos Fernandez
Publikováno v:
Blood. 134:2687-2687
Introduction. Nucleophosmin gene mutation (NPM1mut) occurs in around 30% of acute myeloid leukemia (AML) patients, frequently linked with favourable prognosis in the absence of FLT3-ITDmut, which occurs in around 40% of NPM1mutAML. Therefore, more ex